REFERENCES
- Thein SL. Genetic modifiers of β-thalassemia. Haematologica 2005; 90(5)649–660
- Lee GR, Forester J, Lukens J, Paraskevas F, Greer JP, Rodgers GM. Wintrobe's Clinical Hematology. Williams & Wilkins, Baltimore 1999
- Habibzadeh F, Yadollahie M, Merat A, Haghshenas M. Thalassemia in Iran: an overview. Arch Irn Med 1998; 1(1)27–33
- Vetter B, Schwarz C, Kohne E, Kulozik AE. β-Thalassaemia in the immigrant and non-immigrant German populations. Br J Haematol 1997; 97(2)266–272
- Merat A, Haghshenas M. The spectrum of β-thalassemia mutations in Iran. Med J I R Iran 2000; 14(1)103–106
- Yavarian M, Harteveld CL, Batelaan D, Bernini LF, Giordano PC. Molecular spectrum of β-thalassemia in the Iranian province of Hormozgan. Hemoglobin 2001; 25(1)35–43
- Eshghi P, Zadeh-Vakili A, Rashidi A, Miri-Moghadam E. An unusually frequent β-thalassemia mutation in an Iranian province. Hemoglobin 2007; 32(4)387–392
- Samavat A. Epidemiology of β-thalassemia in Iran. In: Samavat A, Ed. Comprehensive Textbook of Thalassemia. Tehran: Baqiat-allah University Publication 2004; 11–30
- Treisman R, Orkin SH, Maniatis T. Specific transcription and RNA splicing defects in five cloned β-thalassaemia genes. Nature 1983; 302(5909)591–596
- Laosombat V, Wongchanchailert M, Sattayasevana B, Wiriyasateinkul A, Fucharoen S. Clinical and hematological features of β+-thalassemia (IVS-1 nt 5, G - C mutation) in Thai patients. Eur J Haematol. 2001; 67(2)100–104
- Schneider RG. Differentiation of electrophoretically similar hemoglobins–such as S, D, G and P; or A2, C, E, and O–by electrophoresis of the globin chains. Clin Chem 1974; 20(9)1111–1115
- Fairbanks VF, Klee GG. Biochemical aspects of hematology. Tietz Text Book of Clinical Chemistry, CA Burtis, ER Ashwood. WB Saunders Company, Philadelphia 1994; 2041–2042
- Bouva MJ, Harteveld CL, van Delft P, Giordano PC. Known and new δ globin gene mutations and their diagnostic significance. Haematologica 2006; 91(1)129–132
- Najmabadi H, Karimi-Nejad R, Sahebjam S, Pourfarzad F, Teimourian S, Sahebjam F, Amirizadeh N, Karimi-Nejad MH. The β-thalassemia mutation spectrum in the Iranian population. Hemoglobin 2001; 25(3)285–296
- Shokrani M, Terrell F, Turner EA, Aguinaga MD. Chromatographic measurements of Hemoglobin A2 in blood samples that contain sickle hemoglobin. Ann Clin Lab Sci 2000; 30(2)191–194
- Nguyen CK, Le TT, Duong BT, Dinh PH, Ta TH, Tran HH. β-Thalassemia/Haemoglobin E disease in Vietnam. J Trop Pediatr 1990; 36(1)43–45
- Mahboudi F, Zeinali S, Merat A, Delmaghani S, Mostafavipour K, Moghaddam Z, Haghshenas M. The molecular basis of β-thalassemia mutations in Fars Province, Iran. Irn J Med Sci 1996; 21(3)99–104
- Karimi M, Rasekhi AR. Efficiency of premarital screening of β-thalassemia trait using MCH rather than MCV in the population of Fars Province, Iran. Haematologia 2002; 32(2)129–133